Crossmark

Development of novel triconjugates fusing melatonin/isatin/N-acylhydrazone targeting colorectal cancer: design, synthesis, biological, and in silico ADME/Tox profiling

Crossref DOI link: https://doi.org/10.1007/s00044-024-03358-1

Published Online: 2025-01-07

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gutiérrez, Sara M.

Cardona-Galeano, Wilson

Herrera-Ramírez, Angie

Yepes, Andres F.
Funding

Funding for this research was provided by:

Ministerio de Ciencia, Tecnología e Innovación (Code: 121092092332, Contract: 621-2022”. Projects: Nanovehicles 92355 and Preclinical 92391.)

Ministerio de Ciencia, Tecnología e Innovación (Code: 121092092332, Contract: 621-2022”. Projects: Nanovehicles 92355 and Preclinical 92391.)

Ministerio de Ciencia, Tecnología e Innovación (Code: 121092092332, Contract: 621-2022”. Projects: Nanovehicles 92355 and Preclinical 92391.)

Ministerio de Ciencia, Tecnología e Innovación (Code: 121092092332, Contract: 621-2022”. Projects: Nanovehicles 92355 and Preclinical 92391.)
License Information

Text and Data Mining valid from 2025-01-07

Version of Record valid from 2025-01-07
More Information

Article History

Received: 27 August 2024

Accepted: 19 November 2024

First Online: 7 January 2025

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below